'Environmentally-harmless' lice drug developed in Chile

(09/18/19)

A Chilean biotechnology consortium has applied to patent a new antiparasitic which it says produces 100% mortality in both larval-stage and adult sea lice in laboratory tests.

Ictio Biotechnologies is using biological compounds with the aim of establishing a specific, effective treatment that offers little possibility of resistance by the Chilean louse Caligus rogercresseyi and has low environmental impact.

The project’s scientists use protein extracts obtained from a culture of.......................................................


Click here to read the rest of this article:
https://www.fishfarmingexpert.com/